Literature DB >> 7975234

CD4 expressing human 293 cells as a tool for studies in HIV-1 replication: the efficiency of translational frameshifting is not altered by HIV-1 infection.

H Reil1, M Höxter, D Moosmayer, G Pauli, H Hauser.   

Abstract

An adherent human cell line (293) was made susceptible for HIV-1 infection by transfer of a CD4 expression plasmid. These cells could be infected with HIV-1 and produced infectious virus up to a titer of 10(6) TCID50/ml releasing p24 protein up to 1 micrograms/ml. Since they can be efficiently transfected with reporter genes, these cells are a suitable model system to monitor biochemical events during productive infection of HIV-1 and can be used for antiviral drugs. Translational frameshifting determines the balance of the structural Gag versus the catalytic Pol proteins which is probably crucial for correct virus assembly. We have genetically engineered CD4 expressing 293 cells with a sensitive in vivo reporter system to monitor the extent of frameshifting in HIV-1-infected versus uninfected cells. During the time course of productive HIV-1 infection the low efficiency of ribosomal frameshifting is not altered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975234     DOI: 10.1006/viro.1994.1655

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.

Authors:  Hamayun John Sharifi; Andrea K M Furuya; Robert M Jellinger; Michael D Nekorchuk; Carlos M C de Noronha
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

2.  The double-stranded RNA-binding protein, Staufen1, is an IRES-transacting factor regulating HIV-1 cap-independent translation initiation.

Authors:  Hade Ramos; Anne Monette; Meijuan Niu; Aldo Barrera; Brenda López-Ulloa; Yazmín Fuentes; Paola Guizar; Karla Pino; Luc DesGroseillers; Andrew J Mouland; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

3.  Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28).

Authors:  Donatien Mavoungou; Virginie Poaty-Mavoungou; Marie-Yvonne Akoume; Brice Ongali; Elie Mavoungou
Journal:  Virol J       Date:  2005-02-11       Impact factor: 4.099

4.  Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors.

Authors:  Daniel C Farley; Laura McCloskey; Barbara A Thorne; Semih U Tareen; Christopher J Nicolai; David J Campbell; Richard Bannister; Hannah J Stewart; Laura Je Pearson; Bentley J Moyer; Scott H Robbins; Leah Zielinski; Tae Kim; Pippa A Radcliffe; Kyriacos A Mitrophanous; Wayne R Gombotz; James E Miskin; Brenna Kelley-Clarke
Journal:  Mol Ther Methods Clin Dev       Date:  2015-05-13       Impact factor: 6.698

5.  A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx.

Authors:  Christine D Landsberg; Dominik A Megger; Dominik Hotter; Meike U Rückborn; Mareike Eilbrecht; Jassin Rashidi-Alavijeh; Sebastian Howe; Stefan Heinrichs; Daniel Sauter; Barbara Sitek; Vu Thuy Khanh Le-Trilling; Mirko Trilling
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

Review 6.  Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV.

Authors:  Ian Brierley; Francisco J Dos Ramos
Journal:  Virus Res       Date:  2005-11-28       Impact factor: 3.303

7.  The Q-base of asparaginyl-tRNA is dispensable for efficient -1 ribosomal frameshifting in eukaryotes.

Authors:  B Marczinke; T Hagervall; I Brierley
Journal:  J Mol Biol       Date:  2000-01-14       Impact factor: 5.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.